Sales decline 67.39% to Rs 18.41 crore
Net loss of ANG Lifesciences India reported to Rs 3.07 crore in the quarter ended June 2024 as against net profit of Rs 1.75 crore during the previous quarter ended June 2023. Sales declined 67.39% to Rs 18.41 crore in the quarter ended June 2024 as against Rs 56.46 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales18.4156.46 -67 OPM %-9.2311.58 -PBDT-2.514.55 PL PBT-4.142.36 PL NP-3.071.75 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content